Development of PSD95 Inhibitors for the Treatment of Stroke: From Bench to Phase 3 Clinical Trials

Event Date: 
Thursday, February 6, 2014 - 12:00am

Event Presenter

Mike Tymianski, MD/PhD, Director of Neurovascular Therapeutics, Head of Neurosurgery, University Health Network

Weill Cornell Medicine Feil Family Brain & Mind Research Institute 407 E 61st St New York, NY 10065 Phone: (646) 962-8277 Fax: (646) 962-0535